# K212969: Liposaver

- Pathway: 510(k) (Traditional)
- Applicant: Lhbiomed Co., Ltd.
- Decided: Aug 7, 2024 after 1,056 days
- Product code: QPB (System, Suction, Lipoplasty For Removal)
- Device class: 2
- Regulation: 21 CFR 878.5040
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K910696 (1991). 21 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 23 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K190551: VASERlipo System, Solta Medical (2019) Summary page 4.

## Most influential descendants
- K252495: Lssa (NP-200) (2026), 0 descendants of its own

## Indications for use
Liposaver™ is intended for the fragmentation and emulsification of subcutaneous fatty tissues for aesthetic body contouring. Liposaver™ is indicated for use in the following surgical specialists when the fragmentation and aspiration of soft tissue is desired: - Plastic and Reconstruction Surgery - Orthopedic Surgery

Source page: https://510kreport.com/device/K212969
Methodology: https://510kreport.com/methodology